Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$1.4 million.

  • Molecular Partners Ag's Depreciation & Amortization (CF) rose 0.93% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 0.46%. This contributed to the annual value of $2.7 million for FY2024, which is 0.06% down from last year.
  • Molecular Partners Ag's Depreciation & Amortization (CF) amounted to -$1.4 million in Q3 2025, which was down 203.39% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Depreciation & Amortization (CF) peaked at $2.8 million during Q4 2021, and registered a low of -$1.4 million during Q3 2021.
  • Its 3-year average for Depreciation & Amortization (CF) is $482,285, with a median of $693.14 in 2024.
  • Data for Molecular Partners Ag's Depreciation & Amortization (CF) shows a peak YoY increase of 12.95% (in 2022) and a maximum YoY decrease of 13.31% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Depreciation & Amortization (CF) stood at $2.8 million in 2021, then dropped by 10.89% to $2.5 million in 2022, then increased by 10.06% to $2.7 million in 2023, then dropped by 0.88% to $2.7 million in 2024, then increased by 0.93% to -$1.4 million in 2025.
  • Its Depreciation & Amortization (CF) stands at -$1.4 million for Q3 2025, versus $1.3 million for Q2 2025 and $613.96 for Q1 2025.